Erstellt von fchar99
Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals Inc.
WKN: A2AGYB / Symbol: ARWR / Name: Arrowhead Pharma / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
74,86 €
-0,61 %
Arrowhead Pharmaceuticals (ARWR) had its price target raised by B. Riley Financial, Inc. from $101.00 to $123.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat


Neueste Beiträge
Susquehanna in General Dynamics Corp. diskutieren